A possible mechanism that could explain the increased PARP inhibitor sensitivity in DDX11-deficient RCC cells is the involvement of DDX11 in sister chromatid cohesion during replication in the S phase [44]. The gene discussed is DDX11; the disease is renal cell carcinoma.